Back

Marketing Authorisation Holder

LHC Pharmaceuticals (Pty) Ltd

56

Total Medicines

49

Active

0

Dosage Forms

1

Country

South Africa (56)

Registration Status

Registered 49
Canceled 4
Old Medicine 3

Local Agents / Applicants

LHC Pharmaceuticals (Pty) Ltd 56

Registered Medicines

Showing 20 of 56 · Page 1 of 3

Search all
Product Country Status

AMLESSA 8 mg/ 5 mg

None

South Africa Registered

AMLESSA 4 mg/ 10 mg

None

South Africa Registered

AMLESSA 4 mg/ 5 mg

None

South Africa Registered

AMLESSA 8 mg/ 10 mg

None

South Africa Registered

ANTALUKO 10

Montelukast Sodium equivalent to Montelukast

South Africa Canceled

ANTALUKO 4

None

South Africa Registered

ANTALUKO 5

None

South Africa Registered

ATORVASTATIN LHC 10

None

South Africa Registered

ATORVASTATIN LHC 20

None

South Africa Registered

BECLOP

None

South Africa Registered

CELECOXIB 100 mg LHC

None

South Africa Registered

CELECOXIB 200 mg LHC

None

South Africa Registered

COVID-19 VACCINE LHC

SARS-COV-2 (INACTIVATED) ANTIGEN

South Africa Canceled

EMANERA 20 mg

None

South Africa Old Medicine

EMANERA 40 mg

None

South Africa Old Medicine

GABAPENTIN 100 MSQ

Gabapentin

South Africa Registered

GABAPENTIN 300 MSQ

Gabapentin

South Africa Registered

GABAPENTIN 400 MSQ

Gabapentin

South Africa Registered

LAMOTRIGINE 100 MSQ

Lamotrigine

South Africa Registered

LAMOTRIGINE 200 MSQ

Lamotrigine

South Africa Registered